SynthesisJournal of robotic surgery2025
Systematic review and meta-analysis of comparing open and robotic-assisted intracorporeal radical cystectomy: based on randomized controlled trials.
Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aims to compare perioperative outcomes between robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) using totally intracorporeal urinary diversion. We systematically searched PubMed, Web of Science, Cochrane Library, and SpringerLink for randomized controlled trials (RCTs) comparing RARC and ORC until September 2, 2025. Data on operative time, estimated blood loss (EBL), hospital stay length (LOS), lymph node yield, positive surgical margin (PSM) rates, and complication rates at 30 and 90 days were extracted and pooled. A meta-analysis of four RCTs involving 523 patients showed that RARC was associated with a significantly longer operative time (WMD -74.36 min, p < 0.05). However, there were no statistically significant differences between RARC and ORC in EBL, hospital stay, lymph node yield, PSM rates, or the incidence of major and overall complications at both 30-day and 90-day intervals. As the first comparative study focusing exclusively on totally intracorporeal urinary diversion, this analysis demonstrates that RARC, despite longer operative times, achieves perioperative outcomes comparable to ORC. This suggests RARC is a viable surgical alternative in this specific setting. However, these findings are preliminary and require validation through larger, multicenter RCTs with extended follow-up.
Indexed as
Identifiers
41108340What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.